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(SMT 1 m) ou d’un piégeur du peroxynitrite (Acide urique, 100 m). 
La vasorelaxation endothélium indépendante a été évaluée dans 
l’ensemble des cuves avant et après incubation d’H2O2 par ajout 
d’une dose de SNP (10-5 m).
Résultats — Dans des conditions standards, 4 semaines d’exposition 
au CO ne sont pas à l’origine d’une altération de la voie de 
vasorelaxation NO-cGMP. Il est par contre intéressant de noter, 
que les rats CO présentent une sensibilité accrue au stress oxydant 
provoqué par l’incubation d’H2O2 dans les cuves. En effet, 
les rats CO présentent suite à ce stress oxydant une altération 
signi cativement plus marquée de la vasorelaxation endothélium-
dépendante (Ctrl rats : 18 % ; CO rats : 55 %) sans modi cation de 
la vasorelaxation endothélium indépendante. L’utilisation d’un 
inhibiteur spéci que de la NOS2 au cours du stress oxydant permet 
de prévenir les effets aggravants du CO.
Conclusion — Les effets d’une exposition prolongée au CO à des 
concentrations telles que rencontrées en environnement urbain, 
sont masqués dans des conditions standards, mais apparaissent 
majeurs et délétères consécutivement à un stress oxydant aigu au 
H2O2. La NOS2 semble être impliquée de manière majeure dans les 
effets délétères du CO.
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We demonstrated an increase of nitric oxide (NO) production in 
aortas of zucker obese fatty rat (ZOF). Metabolic syndrome is 
associated with an attenuation of acetylcholine (ACh) response. 
The impairment of ACh induced vasodilation suggests a decrease 
in nitric oxide (NO) bioavailability. The aim of this work was to 
assess whether a reduced NO production is involved in the drop 
of NO bioavailability. Male zucker obese fatty (ZOF, n=8) and lean 
(n=9) rats, 31 weeks old, were anesthetized and thoracic aortic 
segments harvested. The NO produced by aortic rings was assayed 
by EPR spectroscopy using colloid Fe(DETC)2 spin-trapping. The 
EPR spectra were obtained using a X-Band EPR spectrometer. Basal 
NO production was signi cantly (p=0.0001) increase (126 %) in 
ZOF rats (3061±201AU/h/mg) from lean controls (1356±101AU/h/
mg). Addition of ACh (3.10-6M) induced an increase in NO levels 
in aortic rings of both ZOF and lean rats, this relative increase 
was signi cantly smaller in ZOF (162±10 vs 270±26 %, p=0.002). 
However the level was higher in ZOF (4905±360 vs 3500±213AU/h/
mg, p=0.004). Without endothelium no NO production was 
detecded in ZOF aortas. A speci c inhibitor of neuronal NOS, Nw-
Propyl-L-arginine (PLA ; 0,1 m), was unable to decreased both NO 
productions : the basal NO production and the ACh-stimulated NO 
production in ZOF aortas. A similar result was obtained with the 
speci c inhibitor of inducible NOS suggesting the only involvement 
of eNOS in increase of NO production observed in ZOF. We conclude 
that the vascular dysfunction observed in metabolic syndrome is 
not due to a decrease in NO production but may be at least in part 
due to a reduced sensitivity to ACh stimulation.
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Resistance arteries have a key role in the control of local blood  ow. 
They are able to remodel in response to chronic increases in  ow 
during growth, exercising or in ischemic diseases. Flow-mediated 
remodelling is governed by the endothelium. The incidence of 
metabolic syndrome increases with age and these 2 risk factors 
reduce endothelium integrity, because of an in ammatory process. 
We hypothesized that in ammation possibly through the induction 
of cycloxygenase-2 (COX2), might affect remodeling in old obese 
rats. In 12-month old obese and lean Zucker rats mesenteric 
resistance arteries were alternatively ligated in vivo so that one 
artery was submitted to high  ow (HF), compare to normal  ow 
(NF) vessels.
After 21 days, outward hypertrophic remodelling in HF arteries 
occurred in obese rats (498±20 in HF arteries vs 443±18 m in NF 
arteries, P<0.01), not in lean rats (454±17 vs 432±14, NS ; n=12 per 
group). Endothelium-dependent (acetylcholine)-relaxation (AMR) 
was reduced in obese compare to lean rats. AMR was reduced by 
NO-synthesis blockade (L-NAME) in all groups and eNOS expression 
was higher in HF than in NF arteries without difference between 
lean and obese rats. Indomethacin further reduced AMR in HF 
from obese rats without signi cantly affecting arteries from 
lean animals. As COX2 immunostaining and expression level was 
evidenced in arteries from obese rats, COX2 inhibition (NS398) 
was tested on AMR. NS398 signi cantly reduced AMR in HF arteries 
in obese rats only. In obese rats chronically treated (3 weeks) with 
NS398 outward remodelling did not occurred in HF arteries.
Thus, COX2 preserved arterial remodelling in response to a chronic 
rise in blood  ow in old obese rats. This adaptation is in favor of a 
better tissue perfusion.
C004
CYCLOOXYGENASE-2 INHIBITION RESTORED 
ENDOTHELIAL-MEDIATED RELAXATION IN OLD 
OBESE
E. VESSIERES 1, E.-J. BELIN DE CHANTEMELE 1, B. TOUTAIN 1, 
A.-L. GUIHOT 1, L. LOUFRANI 1, D. HENRION 1
1 UMR CNRS 6214 Inserm, Angers, France
End-organs perfusion is altered in metabolic diseases due in part to 
a decreased endothelium-mediated relaxation in resistance arteries 
(RA). In ammatory factors including cyclooxygenase-2 (COX2) 
derived agents affect the endothelium to different degrees in aging 
and obesity but the effect of their association on the endothelium 
is not fully understood. We hypothesized that COX2 derivatives 
might reduce endothelium-mediated relaxation in aging associated 
with obesity. RA from 4 and 12 month-old obese Zucker rats RA 
were isolated to measure acetylcholine (endothelium)-mediated 
relaxation (AMR), in vitro, using wire-myography.
Impaired with obesity in young rats, AMR was further reduced 
with aging in old obese rats (89 versus 77 % maximal relaxation, 
young versus old lean rats and 72 versus 51 %, old young versus 
S28 Abstracts
old obese rats). Endothelial NO-synthase (eNOS) blockade 
(L-NAME) was reduced in old obese rats although eNOS expression 
level was unaffected. However, indomethacin improved AMR in 
old obese rats only, suggesting that vasoconstrictor prostanoids 
were involved. Similarly, COX2 inhibition (NS398) and TxA2/PGH2 
receptor blockade (SQ29548) increased AMR in arteries from old 
obese rats only. Old obese rats presented the highest levels of 
blood TxB2 (TxA2 metabolite) associated with an increased COX2 
immunostaining and expression level. Chronic inhibition of COX2 
with NS398 (3 weeks) restored AMR in old obese rats (78 % versus 
57 % in control obese rats) to the level observed in solventtreated 
old lean rats (84 %). Taken together, these data show that obesity 
in old rats is associated with a reduced endothelium-mediated 
relaxation due to an excessive production of COX-2 derivatives, 
most probably TxA2.
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Objective — To study the role of the serotoninergic 5-HT2B 
receptor in the development of cardiac hypertrophy and its link 
with left ventricular superoxide anion generation in a mouse model 
of angiotensin II-induced hypertension.
Methods — Wild-type and 5-HT2B receptor knock-out (KO) mice 
were perfused with angiotensin II (0.2 mg.kg-1.d-1) for 14 days 
with or without SB215505 (1mg.kg-1.d-1), an antagonist of the 
5-HT2B receptor. Heart rate and blood pressure were measured 
by tail-cuff plethysmography. Cardiac hypertrophy was evaluated 
by echocardiography and direct measurement of heart weight. 
Superoxide anion production and maximal NAD(P)H oxidase activity 
were measured by a chemiluminescence method using lucigenin. 
Superoxide anion production was also measured in primary left 
ventricular  broblasts cell cultures.
Results — Angiotensin II increased superoxide anion production 
(+32 %), the maximal activity of NAD(P)H oxidase (+84 %) in left 
ventricle of wild-type mice concomitantly with the arterial blood 
pressure (+37mmHg) and the heart/body weight ratio (+17 %). A 
pharmacological blockade (SB215505) or a genetic suppression of 
the 5-HT2B receptor prevented the increased superoxide anion 
production and cardiac hypertrophy but had no effect on cardiac 
hemodynamics or blood pressure. Angiotensin II also increased 
NAD(P)H oxidase activity in cultured cardiac  broblasts and this 
increase was prevented by SB215505.
Conclusion — The 5-HT2B receptor is a new potential target for the 
prevention of cardiac hypertrophy and its associated superoxide 
anion production. Cells of the extracellular matrix could possibly 
be involved in this mechanism.
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Nitric oxide (NO) production by endothelial NO-synthase (eNOS) is 
critically dependent on the cofactor, tetrahydrobiopterin (BH4). 
Depletion in BH4 consecutive to an increase of reactive oxygen 
species (ROS) production by NADPH-oxidases and/or eNOS over-
expression, favour eNOS uncoupling. This study investigates the 
potential role of NADPH-oxidases and uncoupled eNOS in pulmonary 
arterial hypertension induced by chronic hypoxia.
Male C57BL/6 and eNOS knockout (eNOS-/-) mice were exposed 
or not to hypobaric hypoxia (0.5 atm) for 21 days. Fulton index 
(right ventricular / left ventricular + septum weight ratio) was 
determined. Lungs were used for measurement of BH4 (by HPLC), 
for expression of eNOS (by western-blotting) and of the NADPH-
oxidases subunits Nox1, Nox2 and Nox4 (by RT-PCR). Pulmonary 
arteries were also mounted in a wire myograph for evaluation of 
vasomotor responses.
Chronic hypoxia induced a marked up-regulation of Nox1, Nox2 and 
Nox4 mRNAs in lungs, and an increase of ROS levels in pulmonary 
arteries. BH4 levels, as well as eNOS expression, were enhanced 
in lungs from hypoxic WT mice (1.25 and 4 fold increase compared 
to normoxic WT mice, respectively). In pulmonary arteries from 
hypoxic WT mice, the contractile response to phenylephrine was 
about 1.8 greater than in those from normoxic WT mice. The 
use of ROS scavengers (PEG-SOD or catalase) and NOS inhibitor 
(L-NAME) revealed the involvement of ROS in hypoxia-induced 
hyper-reactivity to phenylephrine, and a loss of NO-dependent 
relaxation. Chronic treatment of hypoxic WT mice with the BH4 
precursor sepiapterin preserved the vasorelaxant effect of NO. This 
treatment and the deletion of eNOS gene abolished the inhibitory 
effect of catalase on phenylephrine-induced contraction, and also 
attenuated hypoxia-induced right ventricular hypertrophy.
These data show that chronic hypoxia induced an up-regulation of 
Nox isoforms and eNOS in lungs. They suggest that uncoupled eNOS 
participates to right ventricular hypertrophy and to alterations 
of vasomotor responses in pulmonary arteries in hypoxia-induced 
pulmonary hypertension. The weak increase in BH4 and the large 
over-expression of eNOS suggest the existence of compensatory 
mechanisms on BH4 synthesis, which may moderate eNOS 
dysfunction.
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